# Safety, Pharmacokinetic Study of PRIC in Healthy Adult Subjects

> **NCT03826485** · PHASE1 · UNKNOWN · sponsor: **SamA Pharmaceutical Co., Ltd** · enrollment: 48 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PRIC
- **DRUG:** Pranlukast hydrate

## Key facts

- **NCT ID:** NCT03826485
- **Lead sponsor:** SamA Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-01
- **Primary completion:** 2019-04-25
- **Final completion:** 2019-07-31
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2019-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03826485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03826485, "Safety, Pharmacokinetic Study of PRIC in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03826485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*